Proposal for standardized prenatal assessment of fetal open dysraphisms by the European reference network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies (ITHACA) and eUROGEN
Prenatal Diagnosis · 2024
DOI: 10.1002/pd.6618 ↗At a glance
Übersichtsarbeit in Prenatal Diagnosis, 2024. Written by Lucie Guilbaud and 7 co-authors. Institution: Fetal Medicine Department, Armand Trousseau University Hospital, Spin@ Reference Center, Sorbonne University, Paris, France. Major MEDLINE topics: Ultrasonography, Prenatal. Cited 13 times so far (Crossref); 100 references. Funded by: Spin@ Reference Center, Paris, France.
Topics: Digitalisierung in der Pflege
Abstract (original language)
Open dysraphisms, that is, myelomeningocele and myeloschisis, are rare diseases associated with a risk of severe disability, including lower limb motor and sensory deficiency, sphincter deficiency, and potential intellectual deficiency. Open dysraphism is diagnosed in Europe in 93.5% of cases. In case of suspicion of fetal open dysraphism, a detailed fetal morphologic assessment is required to confirm the diagnosis and exclude associated structural anomalies, as well as genetic assessment. In case of isolated fetal open dysraphism, assessment of prognosis is based on fetal imaging including the level of the lesion, the presence or not of a sac, the presence and nature of intra cranial anomalies, and the anatomical and functional evaluation of the lower extremities. Based on these biomarkers, a personalized prognosis as well as comprehensive information about prenatal management alternatives will allow parents to decide on further management options. Standardization of prenatal assessment is essential to compare outcomes with benchmark data and make assessment of surgical innovation possible. Herein, we propose a protocol for the standardized ultrasound assessment of fetuses with isolated open dysraphism.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Fetal Medicine Department, Armand Trousseau University Hospital, Spin@ Reference Center, Sorbonne University, Paris, France.
- Maternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Pediatric Radiology Department, Armand Trousseau University Hospital, Sorbonne University, Paris, France.
- Clinical Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
- Institute of Women's Health, University College London, London, UK.
ORCID profiles: Lucie Guilbaud, Jan Deprest, Jean-Marie Jouannic
Funding
- Spin@ Reference Center, Paris, France
Cite
APA
Guilbaud, L., Carreras, E., Garel, C., Maiz, N., Dhombres, F., Deprest, J., Jouannic, J. M., & Workgroup Spina Bifida and other Dysraphisms (SBoD), ITHACA‐eUROGEN European reference networks (2024). Proposal for standardized prenatal assessment of fetal open dysraphisms by the European reference network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies (ITHACA) and eUROGEN. Prenatal Diagnosis. https://doi.org/10.1002/pd.6618
Vancouver
Guilbaud L, Carreras E, Garel C, Maiz N, Dhombres F, Deprest J, et al. Proposal for standardized prenatal assessment of fetal open dysraphisms by the European reference network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies (ITHACA) and eUROGEN. Prenatal Diagnosis. 2024. doi:10.1002/pd.6618
BibTeX
@article{Guilbaud2024,
author = {Guilbaud, Lucie and Carreras, Elena and Garel, Catherine and Maiz, Nerea and Dhombres, Ferdinand and Deprest, Jan and Jouannic, Jean-Marie and Workgroup Spina Bifida and other Dysraphisms (SBoD), ITHACA‐eUROGEN European reference networks, Workgroup Spina Bifida and other Dysraphisms (SBoD), ITHACA‐eUROGEN European reference networks},
title = {Proposal for standardized prenatal assessment of fetal open dysraphisms by the European reference network for Intellectual disability, TeleHealth, Autism and Congenital Anomalies (ITHACA) and eUROGEN},
journal = {Prenatal Diagnosis},
year = {2024},
doi = {10.1002/pd.6618}
}
EUVIMED